Activest Wealth Management’s Filana Therapeutics FLNA Stock Holding History

Activest Wealth Management’s Portfolio FLNA Stock Details FLNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$3.54K	Hold	4,001	–	–	﹤0.01%	744
2026 Q2	$4.76K	Hold	4,001	–	–	﹤0.01%	717
2026 Q1	$6.76K	Hold	4,001	–	–	﹤0.01%	765
2025 Q4	$7.92K	Hold	4,001	–	–	﹤0.01%	704
2025 Q3	$11.6K	Hold	4,001	–	–	﹤0.01%	471
2025 Q2	$7.24K	Hold	4,001	–	–	﹤0.01%	495
2025 Q1	$6K	Hold	4,001	–	–	﹤0.01%	483
2024 Q4	$9.44K	Hold	4,001	–	–	﹤0.01%	324
2024 Q3	$118K	Hold	4,001	–	–	0.04%	110
2024 Q2	$49.4K	Buy	+4,001	New	+$84.3K	0.02%	169

Other funds holding FLNA

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Squarepoint New York $90.8B AUM 26.98% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return

Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $121B AUM 21.47% 1-Year Est. Return

Group One Trading Chicago, Illinois $73.3B AUM 63.67% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $71.4B AUM 33.43% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Simplex Trading Chicago, Illinois $184B AUM 51.71% 1-Year Est. Return

Activest Wealth Management's FLNA Position: Q3 2026 in Review

Activest Wealth Management held its Filana Therapeutics (FLNA) position steady in Q3 2026 at 4,001 shares worth $3.54K. The position accounts for ﹤0.01% of the portfolio, ranked #744.

Activest Wealth Management first reported a position in FLNA in Q2 2024 and has held it in 10 quarters since. The position peaked at $118K in Q3 2024. 44 funds tracked by Wall St. Rank hold FLNA as of Q3 2026.

Activest Wealth Management held 4,001 shares of Filana Therapeutics worth $3.54K as of Q3 2026.
Activest Wealth Management left its Filana Therapeutics share count unchanged in Q3 2026.
Filana Therapeutics made up ﹤0.01% of Activest Wealth Management's portfolio in Q3 2026, its #744 holding.
Activest Wealth Management first reported a position in Filana Therapeutics in Q2 2024 and has held it in 10 quarters since.
Activest Wealth Management's Filana Therapeutics position peaked at $118K in Q3 2024.
44 funds tracked by Wall St. Rank held Filana Therapeutics as of Q3 2026.

Based on Activest Wealth Management's 13F filing for Q3 2026, filed 15 Oct 2026.